Skip to main content
Clinical Trials/TCTR20210706006
TCTR20210706006
Recruiting
Phase 2

Comparison of clinical outcome in dry eye treatment between corneal epithelial thickness assessment with spectral domain optical coherence tomography and clinical assessment

/A0 sites92 target enrollmentJuly 6, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Corneal epithelial thickness measured by spectral domain optical coherence tomography can use for grading dry eye severity and have effect on treatment efficacy
Sponsor
/A
Enrollment
92
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 6, 2021
End Date
January 5, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • Participant diagnosed Dry eye by TFOS DEWS II criteria
  • \- DEQ\-5 Questionnaire not less than 6 with one of the followings
  • \- Non\-invasive Tears film break up time \< 10 second
  • \- Ocular surface staining at cornea \>5 spot or conjunctiva \> 9 spot or eyelid staining length not less than 2 mm and not less than 25 % width

Exclusion Criteria

  • \-other ocular surface disease eg. Epithelial basement membrane dystrophy, Corneal scar, Herpes infection, Recurrent corneal erosion
  • \-eyelid or blinking problem
  • \-other ocular medication eg. glaucoma medication
  • \-contact lens wear
  • \-systemic medication eg.Anti\-histamine, Estrogen replacement therapy, Anti\-depressant, Isotretinoin
  • \-history of ocular trauma or ocular surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials